menu
    • menu

    Company profile for Lupin Manufacturing Solutions

    Mix Gif-PSE
    News
    Lupin Manufacturing Solutions partners with PolyPeptide

    12 Dec 2025

    // PRESS RELEASE

    Lupin Unit Expands CDMO Business With Oncology Block In Vizag

    12 Nov 2025

    // PRESS RELEASE

    LMS Empagliflozin API gets CADIFA approval from ANVISA, Brazil

    24 Sep 2025

    // MEDICALDIALOGUES

    DATA COMPILATION
    #PharmaFlow

    #1

    Contact Supplier

    Website

    DCAT Week

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content

    speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    SERVICES

    Key Products KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Related CompaniesRelated Companies

    About

    Lupin Manufacturing Solutions (LMS), a wholly owned Lupin subsidiary, offers high-quality APIs and end-to-end CDMO services from R&D to commercial scale. Backed by five decades of pharma expertise, LMS combines cost efficiency with regulatory excellence. With world-class sites in Dabhasa and Vizag, and an R&D center in Pune, we deliver integrated, sustainable, and globally compliant solutions that accelerate drug development and reduce environmental impact. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lupin Manufacturing Solutionsindia-flag Flag
    Country
    Country
    India
    Address
    Address
    2nd Floor, Block 12, 13, 14, Art Guild House Wing B, Phoenix Mall, LBS Marg, ...
    Telephone
    Telephone
    +91 2266402323
    Client Email
    Email
    lmsinfo@lupin.com
    Client Website
    Website
    https://www.lmscdmo.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lupin-manufacturing-solutions/
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    INTERVIEW #SpeakPharma

    read-more
    read-more
    “We’re expanding our CDMO capabilities to meet the next wave of complex therapies, starting with oncology.”

    mic“We’re expanding our CDMO capabilities to meet the next wave of complex therapies, starting with oncology.”

    This week, SpeakPharma interviews Dr. Abdelaziz Toumi, Chief Executive Officer of Lupin Manufacturing Solutions (LMS). With over two decades of global leadership experience in the pharmaceutical and manufacturing sectors, Dr. Toumi has been instrumental in shaping LMS’s transformation into a science-driven, client-centric CDMO. Under his leadership, LMS has expanded into complex APIs, oncology manufacturing, and sustainability-led operations. In this exclusive interview with PharmaCompass, Dr. Toumi shares how the company is reshaping its CDMO strategy to serve the evolving needs of global pharma and biotech clients. He also talks about LMS’s latest milestone — the commissioning of a new dedicated oncology block at its Vizag site as the company strengthens its position in high-potency and complex API development ahead of CPHI Frankfurt. Dr. Abdelaziz, Lupin Manufacturing Solutions has been gaining visibility lately. For those who might not be familiar, how would you describe LMS and its vision within the Lupin Group? LMS represents Lupin’s commitment to extending its scientific excellence and manufacturing quality into the CDMO space. LMS was created with a clear vision to collaborate with innovators, biotech firms, and pharmaceutical companies to accelerate their molecules from development to commercial scale, with the assurance of Lupin’s global quality and compliance standards. In essence, LMS blends Lupin’s heritage of trust with the flexibility and customer-focus of a pure-play CDMO. That’s our DNA. HIGHLIGHTS// Extending scientific excellence to CDMO/assurance of global quality, compliance standards/blending heritage of trust with flexibility, customer focus What makes LMS different in an increasingly competitive global CDMO market? The CDMO industry today is not about who has the largest capacity. Rather, it’s about who brings the most value, scientific innovation and speed to the table. Our edge lies in complex chemistry capabilities, deep regulatory expertise, and a culture built around collaboration and accountability. We focus on areas where precision and containment matter, including highly potent APIs (HPAPIs), oncology, and niche small molecules, and we back that up with teams who think beyond manufacturing, toward solving our clients’ development and commercialization challenges. HIGHLIGHTS// Complex chemistry capabilities/deep regulatory expertise/culture built around collaboration and accountability Dr. Abdelaziz, you mentioned oncology as a key focus area. Can you share more about LMS’s plans in this space? Yes, and I am happy to share this first with PharmaCompass — that we have just commissioned our new oncology block at our Vizag site, which is now operationally ready. This is a major step forward for LMS. The facility has been purpose-built for HPAPIs and oncology APIs, and is equipped with advanced containment systems, over 20 reactors and more than 20 isolators. It has a team of over 100 highly skilled scientists specializing in complex and hazardous chemistries. It expands both our capacity and our confidence to support partners in developing targeted cancer therapies. More importantly, it signals our intent — that we are serious about being a global partner of choice in the oncology CDMO space. HIGHLIGHTS// Commissioned new oncology block at Vizag/facility built for HPAPIs, oncology APIs/equipped with advanced containment systems/100 skilled scientists That’s an exciting development. What opportunities do you see in the oncology manufacturing segment globally? The oncology segment is transforming the pharmaceutical landscape. Globally, it is one of the segments with the highest number of development drugs in the pipeline. With the rise of targeted therapies, potent compounds, and smaller-volume high-value APIs, clients are looking for CDMO partners who combine containment expertise with speed and reliability. We see a strong opportunity here, especially as innovators look to move from lab to commercial scale faster, without compromising safety or compliance. LMS is stepping into this gap with the right infrastructure, people, and mindset to deliver. HIGHLIGHTS// Oncology transforming pharmaceutical landscape/highest number of drugs in pipeline/clients looking for CDMOs in oncology space CPHI Frankfurt is around the corner. What can we expect from LMS this year? This CPHI will be a defining one for us. We will be showcasing LMS as a comprehensive small-molecule CDMO, with a sharpened focus on high-potency and oncology manufacturing. Our conversations in Frankfurt will center around how we can help clients navigate development complexity with the confidence of partnering with a science-first, quality-driven CDMO. People will see a refreshed LMS — one that’s growing fast, innovating continuously, and thinking globally. HIGHLIGHTS// Frankfurt CPHI to be a defining one for LMS/helping clients navigate development complexity with confidence/science-first, quality-driven CDMO Quality and sustainability are gaining importance in CDMO partnerships. How is LMS addressing these dimensions? For us, quality and sustainability are a part of our culture. Every process at LMS is anchored in patient safety, compliance, and continuous improvement. Our regulatory systems are built on Lupin’s decades of global experience, and we are leveraging that legacy in every project we take on. On sustainability, we are investing in green chemistry principles, waste minimization, and energy-efficient operations. We believe responsible manufacturing is not just an ESG statement; it’s good business and essential for long-term trust. HIGHLIGHTS// Quality, sustainability part of culture/processes anchored in patient safety, compliance/regulatory systems built on decades of global experience/investing in sustainability Partnership seems to be a recurring theme for LMS. How do you define a true CDMO partnership? A real partnership starts with shared ambition. We see ourselves not just as a manufacturer, but as an innovation partner working as an extension of our client’s R&D and operations teams. The most successful projects we have delivered are those where we have been involved early, and those that align us on the development strategy, risk management, and commercial readiness. That is what we mean when we say we are building science-led partnerships — these are partnerships that are collaborative, transparent, and outcome-driven. HIGHLIGHTS// Innovation partner working as an extension of clients’ R&D, ops team/need to involve LMS early for successful projects/building science-led partnerships Finally, what is next for LMS as you look beyond this milestone? The oncology block is just the beginning of a larger journey. We are scaling our analytical and development services, peptide synthesis capabilities, adding bioconjugation services, expanding global business development, and investing in digital and automation initiatives to make project execution even more seamless. Our goal is to evolve into a trusted global CDMO partner that combines Lupin’s credibility with next-generation manufacturing and scientific agility. As I like to say – we are not just manufacturing APIs; we are manufacturing trust, innovation, and long-term partnerships. HIGHLIGHTS// Scaling analytical, development services, peptide synthesis capabilities/adding bioconjugation services/expanding global business/investing in digital initiatives 

    Impressions: 3573

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology

    PharmaCompass
    22 Oct 2025
    Share info Share

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/lupin-manufacturing-solutions-party-content-65016.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    CDMO Brochure

    read-more

      https://www.pharmacompass.com/pdf/party/content/lupin-manufacturing-solutions-party-content-7394.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Oncology Brochure

    read-more

      https://www.pharmacompass.com/pdf/party/content/lupin-manufacturing-solutions-party-content-41892.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Lupin Manufacturing Solutions partners with PolyPeptide
    Lupin Manufacturing Solutions partners with PolyPeptide

    12 Dec 2025

    // PRESS RELEASE

    https://www.lupin.com/media/press-releases/lupin-manufacturing-solutions-and-polypeptide-announce-strategic-alliance-to-scale-global-peptide-supply-chain

    PRESS RELEASE
    12 Dec 2025
    Share Share
    Lupin Unit Expands CDMO Business With Oncology Block In Vizag
    Lupin Unit Expands CDMO Business With Oncology Block In Vizag

    12 Nov 2025

    // PRESS RELEASE

    https://www.lupin.com/lupin-manufacturing-solutions-unveils-dedicated-oncology-block-at-vizag-india/

    PRESS RELEASE
    12 Nov 2025
    Share Share
    LMS Empagliflozin API gets CADIFA approval from ANVISA, Brazil
    LMS Empagliflozin API gets CADIFA approval from ANVISA, Brazil

    24 Sep 2025

    // MEDICALDIALOGUES

    https://medicaldialogues.in/news/industry/pharma/lupin-manufacturing-solutions-empagliflozin-api-gets-cadifa-approval-from-anvisa-brazil-155251

    MEDICALDIALOGUES
    24 Sep 2025
    Share Share
    We are well-aligned to capitalize on the CDMO opportunity
    We are well-aligned to capitalize on the CDMO opportunity

    06 May 2025

    // PRESS RELEASE

    https://www.lupin.com/media/perspectives/we-are-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology

    PRESS RELEASE
    06 May 2025
    Share Share
    AI& MLReshaping the Future of Pharma Manufacturing
    AI& MLReshaping the Future of Pharma Manufacturing

    13 Jan 2025

    // PRESS RELEASE

    https://www.lupin.com/media/perspectives/abdelaziz-toumi-interview-biovoice-news-jan-2025-issue-integration-of-ai-and-ml-to-play-a-critical-role-in-reshaping-pharma-manufacturing-operations

    PRESS RELEASE
    13 Jan 2025
    Share Share
    CEO of Lupin Manufacturing, Dr. Abdelaziz Toumi’s Interview
    CEO of Lupin Manufacturing, Dr. Abdelaziz Toumi’s Interview

    09 Jan 2025

    // PRESS RELEASE

    https://www.lupin.com/wp-content/uploads/2025/01/dr-abdelaziz-toumi-ceo-lms.pdf

    PRESS RELEASE
    09 Jan 2025
    Share Share

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    Services

    Discover the service capabilities from this company

    Analytical

    Discover their expertise for : Analytical

    API Manufacturing

    Discover their expertise for : API Manufacturing

    Drug Product Manufacturing

    Discover their expertise for : Drug Product Manufacturing

    API & Drug Product Development

    Discover their expertise for : API & Drug Product Development

    KEY SERVICES

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Pop up full-view
    Custom Synthesis and Process Development
    full-view
    Highly Potent API (HPAPI) Manufacturing
    full-view
    Process Development & Scale-Up
    full-view
    Small Molecule API Contract Manufacturing
    full-view

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Contact Lupin Manufacturing Solutions and get a quotation

    Lupin Manufacturing Solutions is a supplier offers 51 products (APIs, Excipients or Intermediates).

    Find a price of Apremilast bulk with DMF, WC offered by Lupin Manufacturing Solutions

    Find a price of Darunavir Ethanolate bulk with DMF, WC offered by Lupin Manufacturing Solutions

    Find a price of Desvenlafaxine Succinate bulk with DMF, WC offered by Lupin Manufacturing Solutions

    Find a price of Deutetrabenazine bulk with DMF, WC offered by Lupin Manufacturing Solutions

    Find a price of Empagliflozin bulk with DMF, WC offered by Lupin Manufacturing Solutions

    Find a price of Eslicarbazepine Acetate bulk with DMF, WC offered by Lupin Manufacturing Solutions

    Find a price of Ferric Citrate bulk with DMF, WC offered by Lupin Manufacturing Solutions

    Find a price of Migalastat bulk with DMF, WC offered by Lupin Manufacturing Solutions

    Find a price of Mirabegron bulk with DMF, WC offered by Lupin Manufacturing Solutions

    Find a price of Pirfenidone bulk with CEP, WC offered by Lupin Manufacturing Solutions

    Find a price of Raltegravir Potassium bulk with DMF, WC offered by Lupin Manufacturing Solutions

    Find a price of Rivaroxaban bulk with DMF, WC offered by Lupin Manufacturing Solutions

    Find a price of Sevelamer Carbonate bulk with DMF, WC offered by Lupin Manufacturing Solutions

    Find a price of Sevelamer Hydrochloride bulk with DMF, WC offered by Lupin Manufacturing Solutions

    Find a price of Sitagliptin Phosphate bulk with DMF, WC offered by Lupin Manufacturing Solutions

    Find a price of Sodium Zirconium Cyclosilicate bulk with DMF, WC offered by Lupin Manufacturing Solutions

    Find a price of Apremilast bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Azilsartan Medoxomil Potassium bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Brivaracetam bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Cannabidiol bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Cysteamine Bitartrate bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Dapagliflozin bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Desvenlafaxine Benzoate bulk with WC offered by Lupin Manufacturing Solutions

    Find a price of Dolutegravir Sodium bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Elagolix Sodium bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Ferric Citrate bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Glycerol Phenylbutyrate bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Iron Sucrose bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Ivacaftor bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Letermovir bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Lurasidone Hydrochloride bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Rufinamide bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Valbenazine Tosylate bulk with DMF offered by Lupin Manufacturing Solutions

    Find a price of Venlafaxine Hydrochloride bulk with WC offered by Lupin Manufacturing Solutions

    Find a price of Alectinib Hydrochloride bulk offered by Lupin Manufacturing Solutions

    Find a price of Azithromycin Dihydrate bulk offered by Lupin Manufacturing Solutions

    Find a price of Baloxavir Marboxil bulk offered by Lupin Manufacturing Solutions

    Find a price of Bupropion Hydrochloride bulk offered by Lupin Manufacturing Solutions

    Find a price of Cabotegravir bulk offered by Lupin Manufacturing Solutions

    Find a price of Cholic Acid bulk offered by Lupin Manufacturing Solutions

    Find a price of Dapagliflozin Propanediol Monohydrate bulk offered by Lupin Manufacturing Solutions

    Find a price of Desvenlafaxine Benzoate bulk offered by Lupin Manufacturing Solutions

    Find a price of Elexacaftor bulk offered by Lupin Manufacturing Solutions

    Find a price of Ferric Carboxymaltose bulk offered by Lupin Manufacturing Solutions

    Find a price of Ferumoxytol bulk offered by Lupin Manufacturing Solutions

    Find a price of Olaparib bulk offered by Lupin Manufacturing Solutions

    Find a price of Orforglipron Calcium Hydrate bulk offered by Lupin Manufacturing Solutions

    Find a price of Piribedil bulk offered by Lupin Manufacturing Solutions

    Find a price of Tetraferric tricitrate decahydrate bulk offered by Lupin Manufacturing Solutions

    Find a price of Tezacaftor bulk offered by Lupin Manufacturing Solutions

    Find a price of Tolvaptan bulk offered by Lupin Manufacturing Solutions

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search